Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (åpner nytt vindu)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Kilde‎: Int J Gynaecol Obstet 2016;134(3):324-8.

Arkiv‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (åpner nytt vindu)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (åpner nytt vindu)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Kilde‎: Cochrane Database Syst Rev 2018;4:CD011689.

Arkiv‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (åpner nytt vindu)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (åpner nytt vindu)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Kilde‎: Am J Obstet Gynecol.

Arkiv‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (åpner nytt vindu)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (åpner nytt vindu)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Kilde‎: S Afr Med J 2016;106(4):399-402.

Arkiv‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (åpner nytt vindu)

Prophylactic use of ergot alkaloids in the third stage of labour. (åpner nytt vindu)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Kilde‎: Cochrane Database Syst Rev 2007;(2):CD005456.

Arkiv‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (åpner nytt vindu)

Treatment for primary postpartum haemorrhage. (åpner nytt vindu)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Kilde‎: Cochrane Database Syst Rev 2014;(2):CD003249.

Arkiv‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (åpner nytt vindu)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (åpner nytt vindu)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Kilde‎: Obstet Gynecol 2001;98(3):386-90.

Arkiv‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (åpner nytt vindu)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (åpner nytt vindu)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Kilde‎: Int J Gynaecol Obstet 2014;127(2):175-9.

Arkiv‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (åpner nytt vindu)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (åpner nytt vindu)

Ragab A, Barakat R, Alsammani MA.

Kilde‎: Int J Gynaecol Obstet 2016;132(1):82-4.

Arkiv‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (åpner nytt vindu)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (åpner nytt vindu)

Roach MK, Abramovici A, Tita AT.

Kilde‎: Am J Perinatol 2013;30(7):523-8.

Arkiv‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (åpner nytt vindu)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (åpner nytt vindu)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Kilde‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

Arkiv‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (åpner nytt vindu)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (åpner nytt vindu)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Kilde‎: Lancet Glob Health. 2023 11(2):e287-e295.

Arkiv‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (åpner nytt vindu)

Intravenous sulprostone infusion in the treatment of retained placenta. (åpner nytt vindu)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Kilde‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

Arkiv‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (åpner nytt vindu)

Carbetocin for preventing postpartum haemorrhage. (åpner nytt vindu)

Su LL, Chong YS, Samuel M.

Kilde‎: Cochrane Database Syst Rev 2012;(4):CD005457.

Arkiv‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (åpner nytt vindu)

Prostaglandins for preventing postpartum haemorrhage. (åpner nytt vindu)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Kilde‎: Cochrane Database Syst Rev 2012;(8):CD000494.

Arkiv‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (åpner nytt vindu)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (åpner nytt vindu)

Westhoff G, Cotter AM, Tolosa JE.

Kilde‎: Cochrane Database Syst Rev 2013;(10):CD001808.

Arkiv‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (åpner nytt vindu)